Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
MR
Maravai LifeSciences Holdings, Inc. Class A Common Stock
MRVI
Mkt Cap
$1.01B
Volume
1.58M
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
MR
MRVI
MR
Maravai LifeSciences Holdings, Inc. Class A Common Stock
MRVI
News
·
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Mkt Cap
$1.05B
Volume
1.58M
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Insider
Filings
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Maravai LifeSciences is under investigation for potential financial reporting irregularities, including revenue recognition errors and potential goodwill impairment, which led to a significant stock price drop.
GlobeNewswire Inc. · Jul 22, 2025
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Maravai LifeSciences is under investigation for potential financial reporting irregularities, including revenue recognition errors and potential goodwill impairment, which led to a significant stock price drop.
GlobeNewswire Inc. · Jul 14, 2025
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Law firm investigating potential claims against Maravai LifeSciences for alleged financial reporting irregularities, including revenue recognition errors and potential goodwill impairment during fiscal 2024.
GlobeNewswire Inc. · Jul 9, 2025
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
A class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (MRVI) for alleged violations of federal securities laws, including inaccurate revenue recognition and overstated goodwill.
GlobeNewswire Inc. · May 5, 2025
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Investors who purchased Maravai LifeSciences Holdings, Inc. securities between August 7, 2024 and February 24, 2025 are encouraged to join a class action lawsuit against the company for alleged securities fraud violations.
Benzinga · May 5, 2025
Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 – MRVI
Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. of a class action securities lawsuit related to alleged securities fraud between August 7, 2024 and February 24, 2025.
GlobeNewswire Inc. · May 2, 2025
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Maravai LifeSciences Holdings, Inc. (MRVI) is facing a class action lawsuit alleging the company made materially false and/or misleading statements about its financial reporting, revenue recognition, and goodwill.
GlobeNewswire Inc. · Apr 30, 2025
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AppLovin, Maravai, e.l.f. Beauty, and Skyworks Solutions and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. has filed class action lawsuits against AppLovin, Maravai, e.l.f. Beauty, and Skyworks Solutions, alleging various financial irregularities and misleading statements by the companies.
GlobeNewswire Inc. · Apr 29, 2025
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman
Maravai LifeSciences Holdings, Inc. reported disappointing Q4 2024 earnings, leading to a significant downgrade by Stifel analysts and a securities class action lawsuit alleging improper accounting practices.
GlobeNewswire Inc. · Apr 28, 2025
MRVI IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – MRVI
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025 of the important May 5, 2025 lead plaintiff deadline in a securities class action lawsuit.
GlobeNewswire Inc. · Apr 27, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
MR
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Buy
Sell
Market
Limit
Soon
MRVI
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any MRVI yet.
Related Tickers
Earnings